Runda Medical(SH:603108) Xin Lang Zheng Quan·2025-09-26 01:23Core Insights - On September 25, RunDa Medical's stock rose by 1.49% with a trading volume of 279 million yuan [1] - The company experienced a net financing outflow of 173,800 yuan on the same day, with a total financing and securities balance of 566 million yuan [1] - As of June 30, 2025, RunDa Medical reported a revenue of 3.47 billion yuan, a year-on-year decrease of 16.08%, and a net profit attributable to shareholders of -121 million yuan, a significant decline of 232.14% [2] Financing and Securities - On September 25, the financing buy-in amount for RunDa Medical was 48.17 million yuan, with a current financing balance of 564 million yuan, representing 5.71% of the market capitalization [1] - The company’s financing balance is below the 10th percentile level over the past year, indicating a low position [1] - In terms of securities lending, 1,300 shares were repaid and 2,000 shares were sold on September 25, with a selling amount of 32,700 yuan [1] Shareholder and Dividend Information - As of June 30, 2025, the number of shareholders for RunDa Medical was 65,500, a decrease of 13.82% from the previous period [2] - The company has distributed a total of 373 million yuan in dividends since its A-share listing, with 165 million yuan distributed in the last three years [3] - New institutional shareholders include招商优势企业混合A and 南方中证1000ETF, while 香港中央结算有限公司 has exited the top ten shareholders list [3]